Accompanying the increase in tumor burden, myeloma-bearing MMP-7−/− mice developed a more severe osteolytic bone disease, with decreased trabecular bone volume (Fig. 2a) and an increase in osteolytic lesions (Fig. 2b) as compared with myeloma-bearing WT mice. Here, MMP7 is linked to neoplasm.